The Mandal Commission and Mandalisation

Nanotechnology offers the unprecedented and paradigm-changing opportunity to study and interact with normal and cancer cells in real time, at the molecular and cellular scales, and during the earliest stages of the cancer process. Through the concerted development of nanoscale devices or devices with nanoscale materials and components, the NCI Alliance for Nanotechnology in Cancer will facilitate in near future their integration within the existing cancer research infrastructure. Nanotechnology is manipulating matter at nanometer level and the application of the same to medicine is called nanomedicine. Nanotechnology holds promise for advanced diagnostics, targeted drug delivery, and biosensors. In the long-term, medical nanorobots will allow instant pathogen diagnosis and extermination, individual cell surgery in vivo, and improvement of natural physiological function. Nanotechnology is expected to have a dramatic impact on medicine. The application of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems is now often referred to as nanomedicine. Among many possible applications of nanotechnology in medicine, the use of various nanomaterials as pharmaceutical delivery systems for drugs, DNA, and imaging agents has gained increasing attention. Many varieties of nanoparticles are available, such as different polymeric and metal nanoparticles, liposomes, niosomes, solid lipid particles, micelles, quantum dots, dendrimers, microcapsules, cells, cell ghosts, lipoproteins, and different nanoassemblies. The book will serve as an ultimate resource book for everyone who would like to know the wide range of prospects in the emerging applications of Nanotechnology for Cancer Therapy.